Skip to main content
Clinical Trials/NCT03623178
NCT03623178
Completed
Not Applicable

Assertive Community Treatment for Patients Suffering From Substance Use

University Hospital, Geneva1 site in 1 country29 target enrollmentDecember 1, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Substance Use Disorders
Sponsor
University Hospital, Geneva
Enrollment
29
Locations
1
Primary Endpoint
Treatment adherence
Status
Completed
Last Updated
11 months ago

Overview

Brief Summary

According to the World Health Organization the population suffering from addiction problems is increasing. This population is characterized by multiple needs at the medico-psychosocial level. However, some of these patients, a particular subgroup that we are going to be interested in the so-called "high need" user group, find it difficult to access and stay in outpatient treatment programs. Persons with substance use disorder often present a chaotic use of the health system, including a high number of hospitalizations in times of crisis. These individuals also show very low utilization of health care services, accompanied by social marginalization. This can be related to relapses and poor social functioning. A high number of relapses occur particularly at the end of hospitalization. Community Interventions, such as Assertive Community Treatment (ACT) should increase the adherence of these patients to treatment by accompanying them in the community and helping them during sensitive and crisis periods. One of the objectives of the study is to evaluate the impact of ACT on the time until service disengagement, measuring treatment adherence. The secondary objectives of this study will be to see the effect of ACT on duration and type of hospitalizations, as well as the number of emergency room visits. The investigators will focus on the impact of ACT on the participant's medico-psycho-social network, substance use and other psychological variables. The investigators will also evaluate his or her psychiatric symptoms and global and social functioning. Life satisfaction and satisfaction with the care received will also be measured. The study will investigate this through questionnaires at the beginning of care, at three months, six months and 12 months after the start of the ACT intervention.

Registry
clinicaltrials.gov
Start Date
December 1, 2017
End Date
December 1, 2023
Last Updated
11 months ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Louise Penzenstadler

Principal investigator

University Hospital, Geneva

Eligibility Criteria

Inclusion Criteria

  • Substance use disorder
  • Competent subjects, able to give informed consent
  • French speaking

Exclusion Criteria

  • Evidence of organic brain disease or learning disability based on the chart review.

Outcomes

Primary Outcomes

Treatment adherence

Time Frame: at 12 months

Number of days until service disengagement

Secondary Outcomes

  • Service use(at 12 months)
  • Patient network(0, 3, 6, 12 months)
  • Number of ER visits(0, 3, 6, 12 months)
  • Addictive behaviour(0, 3, 6, 12 months)
  • General psychiatric symptoms(0, 3, 6, 12 months)
  • Global Functioning(0, 3, 6, 12 months)
  • General life satisfaction: Satisfaction With Life Scale(0, 3, 6, 12 months)

Study Sites (1)

Loading locations...

Similar Trials